Could a Urine Test Help Detect Breast Cancer Earlier?

New research uses artificial intelligence and electronic sensors to explore a noninvasive approach to breast cancer screening

3 Things You Should Know About Breast Cancer Genetic Risk

Moffitt Cancer Center expert debunks myths about family history and BRCA mutations

Moffitt Trial Reports Higher Survival for HER2-Positive Breast Cancer Patients With Leptomeningeal Metastases

The phase 2 trial shows patients treated with radiation therapy followed by two antibodies delivered intrathecally had a median overall survival of 36 months

How Oncoplastic Surgery Is Changing Breast Cancer Care

Moffitt surgeons are giving patients more options that prioritize successful treatment, quality of life and confidence after breast cancer

Breast cancer health care provider in white coat with stethoscope and pink ribbon holds hands with a patient

What Do These Breast Cancer Terms Mean?

Moffitt Cancer Center expert breaks down the language used to describe the disease

New Initiative Hopes To Bring Clinical Trials to Breast Cancer Patients in Barbados

Women on the Caribbean island are more likely to be diagnosed with an aggressive form of the disease

Food for Thought

How Moffitt’s PEARL Kitchen Is Transforming Cancer Nutrition Research

When Jenny De Furio was diagnosed with stage 3C breast cancer in 2024, she decided to go on a clinical trial rather than start with the standard of care treatment. She embraced the chance to be part of a more personalized experimental approach.

Thinking Outside the Box With Adaptive Breast Cancer Clinical Trial

Adaptive clinical trial gives earlier stage breast cancer patient chance to pioneer next generation of treatments

Surgery has long been the standard of care for women with ductal carcinoma in situ, or noninvasive stage 0 breast cancer.

Is Surgery the Only Option for Women With Stage 0 Breast Cancer?

RECAST clinical trial explores estrogen blockers as a nonsurgical approach

Endeavor

Cambiar el idioma